Search Within

Advanced Practice Providers

  1. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (21)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Department of Medicine (56)
  2. Genitourinary Oncology Service (56)
  3. Solid Tumor Oncology Division (56)
  4. Nursing (47)
  5. Epidemiology and Biostatistics (31)
  6. GSK Faculty (23)

More Groups

People
  1. Robert Motzer (20)
  2. Darren Feldman (18)
  3. Howard Scher (13)
  4. Maria Arcila (13)
  5. George Bosl (12)
  6. Sujata Patil (12)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Cancer (3)
  3. European Urology (2)
  4. European Urology Focus (2)
  5. Investigational New Drugs (2)
  6. BJU International (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (32)
  2. Elsevier Science, Inc. (5)
  3. Wiley Blackwell (4)
  4. Springer (3)
  5. American Association for Cancer Research (2)
  6. Elsevier B.V. (2)

More Publishers

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer
    Journal Article

    Reidy, D. L.; Vakiani, E.; Fakih, M. G.; Saif, M. W.; Hecht, J. R.; Goodman-Davis, N.; Hollywood, E.; Shia, J. R.; Schwartz, J.; Chandrawansa, K.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Methylphenidate for fatigue in ambulatory men with prostate cancer
    Journal Article

    Roth, A. J.; Nelson, C.; Rosenfeld, B.; Scher, H.; Slovin, S.; Morris, M.; O'Shea, N.; Arauz, G.; Breitbart, W.
    Cancer (2010)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Turkula, S.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Carousso, M.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Bicalutamide for advanced prostate cancer: The natural versus treated history of disease
    Journal Article

    Scher, H. I.; Liebertz, C.; Kelly, W. K.; Mazumdar, M.; Brett, C.; Schwartz, L.; Kolvenbag, G.; Shapiro, L.; Schwartz, M.
    Journal of Clinical Oncology (1997)

    Fulltext@MSK | Save
  • Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatc cancer: A trial with 10-ethyl-deaza-aminopterin
    Journal Article

    Schultz, P. K.; Kelly, W. K.; Begg, C.; Liebertz, C.; Cohen, L.; Scher, H. I.
    Urology (1994)

    Fulltext@MSK | Save